Medicared For All Logo

Amer Kazi MD in Laporte, Indiana

Home Indiana Laporte

Amer Kazi MD has Pain Management as his primary medical specialty. Their primary office is: 286 W Johnson Rd E in Laporte, Indiana. They attended Sorry, his university is not listed and graduated in 1987 (around 37 years of experience). They are listed as doing telehealth appointments.

Amer Mahmud Kazi MD Office Phone and Directions

Amer Kazi MD
286 W Johnson Rd E
Laporte, Indiana 46350
574-234-2191

Patient Ratings
Please rate your experience with Amer Kazi MD below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 574-234-2191


Enter a starting address:


Healthcare Info for Amer Kazi MD

Medical School: Sorry, his university is not listed
Graduation Year: 1987
The Primary Medical Specialty for Amer Kazi MD is listed as: Pain Management
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 37
PAC (PECOS ID)#: 5991772998
NPI #: 1134122914
NPI Created On: 05/24/2005
NPI Last Updated Listed as: 02/25/2020
Primary Taxonomy Code: 2084N0400X
License Number:
01059304A
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

  • Humana
  • CareSource
  • Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Urdu, Punjabi, Hindi.

Services and Procedures include:

  1. Aspiration and/or injection of major joint or joint capsule with recording and reporting using ultrasound guidance
  2. Injection procedure into sacroiliac joint for anesthetic or steroid
  3. Injections of anesthetic and/or steroid drug into lower or sacral spine nerve root using imaging guidance
  4. Injections of anesthetic and/or steroid drug into lower or sacral spine nerve root using imaging guidance
  5. Injections of lower or sacral spine facet joint using imaging guidance
  6. Injections of lower or sacral spine facet joint using imaging guidance
  7. Injections of lower or sacral spine facet joint using imaging guidance
  8. Destruction of lower or sacral spinal facet joint nerves using imaging guidance
  9. Destruction of lower or sacral spinal facet joint nerves with imaging guidance
  10. Testing for presence of drug
  11. Vitamin d-3 level
  12. New patient office or other outpatient visit, typically 45 minutes
  13. New patient office or other outpatient visit, typically 60 minutes
  14. Established patient office or other outpatient visit, typically 15 minutes
  15. Established patient office or other outpatient, visit typically 25 minutes
  16. Established patient office or other outpatient, visit typically 40 minutes
  17. Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms
  18. Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms
  19. Injection, dexamethasone sodium phosphate, 1 mg

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $17

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 789454447

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Opioid Analgesic

Name of Drug #1: XTAMPZA

Open Associated Drug #1: 24510-110-10

Payments Total: $18

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 789454453

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Opioid Analgesic

Name of Drug #1: XTAMPZA

Open Associated Drug #1: 24510-110-10

Payments Total: $14

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 789454457

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Opioid Analgesic

Name of Drug #1: XTAMPZA

Open Associated Drug #1: 24510-110-10

Payments Total: $17

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 789454463

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Opioid Analgesic

Name of Drug #1: XTAMPZA

Open Associated Drug #1: 24510-110-10

Payments Total: $16

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 789454467

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Opioid Analgesic

Name of Drug #1: XTAMPZA

Open Associated Drug #1: 24510-110-10

Payments Total: $17

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 789454473

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Opioid Analgesic

Name of Drug #1: XTAMPZA

Open Associated Drug #1: 24510-110-10

Payments Total: $16

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 792509063

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: non-opioid analgesic

Name of Drug #1: Licart

Open Associated Drug #1: 71858-0305-5

Payments Total: $15

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 792509065

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: non-opioid analgesic

Name of Drug #1: Licart

Open Associated Drug #1: 71858-0305-5

Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 792531665

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: OBESITY

Name of Drug #1: CONTRAVE

Open Associated Drug #1: 51267-890-99

Payments Total: $750

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 792829787

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: NEUROSCIENCE

Name of Drug #1: UBRELVY

Open Associated Drug #1: 0023-6501-10

Providers in the same medical group

1.Jon Aagaard

2001 N Gary Ave
Wheaton Il 60187-3055
Family Practice

2.Matthew Aaker

8055 W Ave
Castle Hills Tx 78213-1842
Optometry

3.Justin Aaker

3613 Williams Dr
Georgetown Tx 78628-1373
Ophthalmology

4.Mohammad Aalai

7005 35th Ave
Jackson Heights Ny 11372-3970
Physical Medicine And Rehabilitation

5.Carol Aalbers Cp

4560 S Carson St
Carson City Nv 89701-6915
Clinical Psychologist

6.Hina Aamir

602 S Atwood Rd
Bel Air Md 21014-4323
Psychiatry


Medicared For All
Vote!
Share